Biotherapeutics applications

Profile A private company, Neugenesis was founded in 1992 by several key individuals who recognized the potential commercial value of Neurospora for biotechnology applications. It has nine employees and occupies a 1600 square foot facility for its headquarters and R D facilities. The company uses proprietary combinatorial biology technology to discover and develop new biotherapeutics, both alone and in partnership with other biopharmaceutical companies. 

A key physiochemical trait of chitosan is its unique molecular structure, which contains abundant reactive hydroxyl and amino functional groups. These functional groups provide anchor sites for further conjugation of functional molecules to chitosan. The abundant amino functional groups present in the molecular structure of chitosan also ensure a net cationic character, which enables electrostatic com-plexation with anionic drugs and biotherapeutics. Combined, these functionalities render chitosan highly amendable to further modification, and a desirable polymer platform for a broad range of biomedical applications. 

---